D2G2 Research
Delivery of Drugs and Genes Group
Delivery of Drugs and Genes Group
Delivery of Drugs and Genes Group

Delivery of Drugs and Genes Group - D2G2

The D2G2 Group, led by Professor Mark Kendall, focuses on fundamental research and applied techniques for needle-free vaccination delivery systems.

One of our foremost developments is the Nanopatch developed at the Australian Institute for Bioengineering & Nanotechnology (AIBN).

Find out more about our research

See more of our work in action